Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : email@example.com
SNX281 acts as an agonist to stimulator of interferon genes (STING, TMEM173), which activates the immune system by stimulating cells in the tumor microenvironment, potentially resulting in a cytotoxic T-lymphocyte response against tumor cells (NCI Drug dictionary).
|DrugClasses||STING1 Agonist 15|
|CAS Registry Number||NA|
|Therapy Name||Drugs||Efficacy Evidence||Clinical Trials|
|Pembrolizumab + SNX281||Pembrolizumab SNX281||0||1|